BREAKING
Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 minutes ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 hour ago Abbott reports positive results from study on its atrial fibrillation therapies 2 hours ago Atmus Welcomes Heath Sharp to Board of Directors 4 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Tech Giants Report Record Q4 Earnings, Beat Wall Street Estimates 1 week ago Oil Prices Surge 5% on Middle East Supply Disruption Fears 1 week ago Graham Corporation Sees Robust Q3 on Defense Momentum and FlackTek Integration 3 minutes ago Biogen’s Q4 FY25 adj. earnings decline, but beat estimates; revenue down 7% 1 hour ago Abbott reports positive results from study on its atrial fibrillation therapies 2 hours ago Atmus Welcomes Heath Sharp to Board of Directors 4 hours ago Zurn Elkay beats fourth quarter estimates, forecasts growth for 2026 2 days ago Yum China Reports Fourth Quarter and Full Year 2025 Financial Results 2 days ago BrightView Q1 2026 Results: Revenue Beats Expectations but Profitability Challenges Weigh on Stock 2 days ago Fed Signals Potential Rate Cuts Amid Cooling Inflation Data 1 week ago Tech Giants Report Record Q4 Earnings, Beat Wall Street Estimates 1 week ago Oil Prices Surge 5% on Middle East Supply Disruption Fears 1 week ago
ADVERTISEMENT
AlphaGraphs

Pfizer (PFE) Q2 2024 Earnings: Key financials and quarterly highlights

Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today. Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally. Reported net income fell 98% to $41 million, or $0.01 per share, compared to last year. Adjusted EPS dropped 11% to $0.60. For the full year of 2024, Pfizer expects revenues of […]

$PFE July 30, 2024 1 min read

Pfizer Inc. (NYSE: PFE) reported its second quarter 2024 earnings results today.

Revenues increased 2% year-over-year to $13.3 billion. Revenues grew 3% operationally.

Reported net income fell 98% to $41 million, or $0.01 per share, compared to last year. Adjusted EPS dropped 11% to $0.60.

For the full year of 2024, Pfizer expects revenues of $59.5-62.5 billion. Adjusted EPS is expected to be $2.45-2.65.

Prior performance

ADVERTISEMENT